Cargando…
From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Immunological Considerations
Mesenchymal stem cell (MSC)-based therapy for type 1 diabetes mellitus (T1DM) has been the subject matter of many studies over the past few decades. The wide availability, negligible teratogenic risks and differentiation potential of MSCs promise a therapeutic alternative to traditional exogenous in...
Autores principales: | Refaie, Ayman F., Elbassiouny, Batoul L., Kloc, Malgorzata, Sabek, Omaima M., Khater, Sherry M., Ismail, Amani M., Mohamed, Rania H., Ghoneim, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262452/ https://www.ncbi.nlm.nih.gov/pubmed/34248981 http://dx.doi.org/10.3389/fimmu.2021.690623 |
Ejemplares similares
-
From Mesenchymal Stromal/Stem Cells to Insulin-Producing Cells: Progress and Challenges
por: Ghoneim, Mohamed A., et al.
Publicado: (2020) -
Transplantation of insulin-producing cells derived from human mesenchymal stromal/stem cells into diabetic humanized mice
por: Ghoneim, Mohamed A., et al.
Publicado: (2022) -
PRDX6 Promotes the Differentiation of Human Mesenchymal Stem (Stromal) Cells to Insulin-Producing Cells
por: Gabr, Mahmoud M., et al.
Publicado: (2020) -
Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal
Cells Could Control Chemically Induced Diabetes in Dogs: A Preliminary Study
por: Gabr, Mahmoud M., et al.
Publicado: (2018) -
Generation of Insulin-Producing Cells from Human Bone Marrow-Derived Mesenchymal Stem Cells: Comparison of Three Differentiation Protocols
por: Gabr, Mahmoud M., et al.
Publicado: (2014)